CD39 Inhibitor
45-16 Ramsey Road, Shirley, NY 11967, USA, Long Island City, New York, 11967
About us
The CD39 ectonucleotidase triphosphate diphosphohydrolase 1 (Entpd1) represents a new promising target for cancer immunotherapy. CD39 is expressed on both regulatory T cells and tumor cells and plays a major role in promoting immunosuppression.
https://www.bocsci.com/tag/cd39-17.html